These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 37249297)

  • 21. Polo-like kinase 1 promotes sepsis-induced myocardial dysfunction.
    Gao Z; Zheng C; Xing Y; Zhang X; Bai Y; Chen C; Zheng Y; Wang W; Zhang H; Meng Y
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111074. PubMed ID: 37879229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of initial natriuretic peptides in the setting of sepsis-induced myocardial dysfunction.
    He B; Wang X; Shi L; Cheng H; Zhao L
    Biomark Med; 2024 Feb; 18(4):145-155. PubMed ID: 38380989
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis.
    Chen FC; Xu YC; Zhang ZC
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):537-548. PubMed ID: 32633108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and Predictive Value of LncRNA MCM3AP-AS1 in Sepsis and Its Regulatory Role in Sepsis-Induced Myocardial Dysfunction.
    Wei Y; Bai C; Xu S; Cui M; Wang R; Wu M
    Cardiovasc Toxicol; 2024 Oct; 24(10):1125-1138. PubMed ID: 39085530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation.
    Gao F; Yang YZ; Feng XY; Fan TT; Jiang L; Guo R; Liu Q
    Cytokine; 2016 Dec; 88():1-11. PubMed ID: 27525353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the mTOR Signalling Pathway in Human Sepsis-Induced Myocardial Dysfunction.
    Cheng Mm W; Long Y; Wang H; Han Mm W; Zhang J; Cui N
    Can J Cardiol; 2019 Jul; 35(7):875-883. PubMed ID: 31292086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of Long Noncoding RNA MIAT Contributes to Relieving Sepsis-Induced Myocardial Depression via the NF-κB Axis.
    Chen H; Meng S; Liu C; Liu F; Ding F; Hu Y; Cheng Z
    J Surg Res; 2022 Oct; 278():282-292. PubMed ID: 35636204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Gut Dysbiosis and Sepsis-Induced Myocardial Dysfunction in Patients With Sepsis or Septic Shock.
    Chen Y; Zhang F; Ye X; Hu JJ; Yang X; Yao L; Zhao BC; Deng F; Liu KX
    Front Cell Infect Microbiol; 2022; 12():857035. PubMed ID: 35372123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The small molecule PSSM0332 disassociates the CRL4A
    Peng Q; Xu H; Xiao M; Wang L
    Int J Biol Sci; 2020; 16(15):2974-2988. PubMed ID: 33061810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-214-3p Attenuates Sepsis-Induced Myocardial Dysfunction in Mice by Inhibiting Autophagy through PTEN/AKT/mTOR Pathway.
    Sang Z; Zhang P; Wei Y; Dong S
    Biomed Res Int; 2020; 2020():1409038. PubMed ID: 32714974
    [No Abstract]   [Full Text] [Related]  

  • 31. FAM46C inhibits lipopolysaccharides-induced myocardial dysfunction via downregulating cellular adhesion molecules and inhibiting apoptosis.
    Tan J; Sun T; Shen J; Zhu H; Gong Y; Zhu H; Wu G
    Life Sci; 2019 Jul; 229():1-12. PubMed ID: 30910647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [SEPTIC CARDIOMYOPATHY].
    Vincelj J
    Acta Med Croatica; 2015 Sep; 69(3):177-82. PubMed ID: 29077374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation and treatment of sepsis-induced myocardial dysfunction: a systematic study].
    Yu L; Sun R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):378-380. PubMed ID: 30914106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myocardial dysfunction in sepsis--definition and pathogenetic mechanisms].
    Muriová K; Maláska J; Otevrel F; Slezák M; Kratochvíl M; Sevík P
    Vnitr Lek; 2010 Mar; 56(3):220-5. PubMed ID: 20394208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clemastine protects against sepsis-induced myocardial injury
    Wang X; Xie D; Dai H; Ye J; Liu Y; Fei A
    Bioengineered; 2022 Mar; 13(3):7134-7146. PubMed ID: 35274595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of sepsis-induced cardiomyopathy.
    Hollenberg SM; Singer M
    Nat Rev Cardiol; 2021 Jun; 18(6):424-434. PubMed ID: 33473203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the TXNIP-NLRP3 interaction with PSSM1443 to suppress inflammation in sepsis-induced myocardial dysfunction.
    Wang L; Zhao H; Xu H; Liu X; Chen X; Peng Q; Xiao M
    J Cell Physiol; 2021 Jun; 236(6):4625-4639. PubMed ID: 33452697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproic acid attenuates sepsis-induced myocardial dysfunction in rats by accelerating autophagy through the PTEN/AKT/mTOR pathway.
    Shi X; Liu Y; Zhang D; Xiao D
    Life Sci; 2019 Sep; 232():116613. PubMed ID: 31265853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sepsis-induced cardiomyopathy.
    Romero-Bermejo FJ; Ruiz-Bailen M; Gil-Cebrian J; Huertos-Ranchal MJ
    Curr Cardiol Rev; 2011 Aug; 7(3):163-83. PubMed ID: 22758615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between right ventricle dysfunction and poor outcome in patients with septic shock.
    Kim JS; Kim YJ; Kim M; Ryoo SM; Kim WY
    Heart; 2020 Nov; 106(21):1665-1671. PubMed ID: 32641318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.